共 50 条
- [42] Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors [J]. FRONTIERS IN IMMUNOLOGY, 2025, 16
- [44] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity [J]. Current Treatment Options in Oncology, 2022, 23 : 1153 - 1168
- [47] Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy [J]. CANCER MEDICINE, 2020, 9 (23): : 9027 - 9035
- [48] Immunotherapy in Older Adults With Cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (19) : 2115 - +
- [50] Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9